Sudeep Pharma IPO — Date, Price Band, GMP & Allotment 2025
**Sudeep Pharma** IPO is attracting good interest from investors. The company is engaged in manufacturing and supplying pharmaceutical excipients and specialty chemicals used in medicines and healthcare products. It has a strong presence in both domestic and export markets. The IPO aims to raise funds for business expansion, working capital needs, and strengthening its market position. Investors are watching the issue considering its growth potential and industry demand.
IPO Review
IPO GMP
IPO Subscription Subscription
Stock Price
As the IPO is listed, here is the Live Share Price for Sudeep Pharma
IPO Summary
What is the Sudeep Pharma IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 21 Nov, 2025 | Friday |
| IPO Close Date | 25 Nov, 2025 | Tuesday |
| Basis of Allotment | 26 Nov, 2025 | Wednesday |
| Refunds Initiated | 27 Nov, 2025 | Thursday |
| Credit to Demat | 27 Aug, 2025 | Wednesday |
| Listing Date | 28 Nov, 2025 | Friday |
What is the Sudeep Pharma IPO Lot Size?
Bidding in multiples of 25 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 25 | ₹14,825 |
| Retail (Max) | 13 | 325 | ₹1,92,725 |
| S-HNI (Min) | 14 | 350 | ₹2,07,550 |
| S-HNI (Max) | 67 | 1675 | ₹9,93,275 |
| B-HNI (Min) | 68 | 1700 | ₹10,08,100 |
About Sudeep Pharma
The company primarily manufactures calcium-based and mineral ingredients such as calcium carbonate, calcium citrate, and other specialty compounds widely used in tablets, dietary supplements, and fortified food products. Its business model is largely B2B, supplying to pharmaceutical companies, nutraceutical brands, and global distributors. By focusing on quality certifications, scalable manufacturing, and long-term client relationships, the company aims to sustain growth and expand its footprint in regulated and semi-regulated markets worldwide.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
Sudeep Pharma Key Performance Indicators (KPIs)
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
| Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I | ₹75.81 Cr. |
| General corporate purposes | ₹12.67 Cr. |
Company Financials
The Sudeep Pharma company's financial performance (in ₹ Cr.) is summarized below:
| Metric | 31 Mar 24 | 31 Mar 23 | 31 Mar 22 |
|---|---|---|---|
| Revenue | 565.55 | 959.21 | 475.51 |
| OPM % | 7.65 | ||
| EBITDA | 84.11 | 107.97 | 57.82 |
| Net Profit | -16.98 | -102.35 | -71.70 |
| Debt | 533.51 | 437.06 | 384.79 |
| Assets | 2,134.35 | 1,859.84 | 1,863.50 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Promoters and Shareholding Details
Promoter holding details will be updated as soon as they are officially announced.
Frequently Asked Questions
What is the GMP of Sudeep Pharma?
The current Grey Market Premium (GMP) of Sudeep Pharma is ₹ 0.
What is the Sudeep Pharma IPO Price Band?
The price band for Sudeep Pharma IPO is ₹563 to ₹593.
When is the Sudeep Pharma IPO Allotment?
The allotment date for Sudeep Pharma IPO is November 26, 2025.
How to check Sudeep Pharma IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website (MUFG Intime India Pvt.Ltd.).
Official Documents
Company Contact Details
Sudeep Pharma
129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340
+91 265 284 0656
Registrar
MUFG Intime India Pvt.Ltd.
Book Running Lead Manager
ICICI Securities Ltd.
Discussion 0
No comments yet
Be the first to share your thoughts!